🇺🇸 FDA
Patent

US 9675583

Selective androgen receptor modulators (SARMS) and uses thereof

granted A61KA61K31/401A61K31/402

Quick answer

US patent 9675583 (Selective androgen receptor modulators (SARMS) and uses thereof) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/401, A61K31/402, A61K31/5383, A61K45/06